Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized controlled study of intramuscular PLX-PAD for severe COVID-19 with ARDS
MOH_2020-10-05_009163Phase 2Active, not recruiting
- Sponsor
- Pluri Inc.
- Start
- Oct 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) and acute respiratory distress syndrome (ARDS) comparing PLX-PAD + standard of care with Standard of care control (2 arms). Started Oct 2020; status: active, not recruiting.
02
Drugs
PLX-PAD
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on MOH_2020-10-05_009163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-10-05_009163.